Frontiers in Endocrinology is a peer-reviewed, open-access journal launched in 2010 as part of the Frontiers Media platform. It publishes work in molecular, clinical, translational, and systems endocrinology, organized into 20+ specialty sections.

• Indexed in: PubMed/MEDLINE, Scopus, Web of Science, DOAJ
• Impact Factor (2024): ≈ 4.39
• CiteScore (Scopus): ≈ 6.1
• SJR (2024): 1.472
• Google Scholar h-index: ~83

• Mid-tier reputable journal with high visibility and citations.
• Fully open-access, improving dissemination.
• Transparent review: reviewers are named upon publication.
• Active editorial engagement across specialty sections.

• Associated with Frontiers Media, which has drawn criticism for:
  1. High publication volume and rapid processing.
  2. Previous listing in Beall’s (now defunct) list of predatory publishers (2015–2017).
  3. Internal conflicts in some other Frontiers journals (not this one).
• Concerns about:
  1. Reviewer recruitment automation, potential dilution of quality.
  2. Special issue inflation, guest-edited volumes with variable rigor.

• Single-anonymized and interactive: authors see comments; reviewers and editors are named.
• Review process includes direct discussion between reviewers and editors via a collaborative platform.
• Average time from submission to acceptance: ~90 days.
• Authors may appeal decisions through structured editorial channels.

• Considered a legitimate, mainstream journal in the field of endocrinology.
• Rated as “Pro-Science” and “Mostly Factual” by independent watchdogs.
• No major retraction scandals or misconduct history specific to this journal.

• 'Frontiers in Endocrinology' is a solid open-access journal for endocrine research, with competitive metrics and broad reach.
• While affiliated with a publisher that has been criticized for scale and pace, the journal itself maintains standard scientific integrity.
• Suitable for well-structured original research, especially if rapid publication and open-access visibility are priorities.